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ABSTRACT
Background Deaths during the COVID-19 pandemic
result directly from infection and exacerbation of other
diseases and indirectly from deferment of care for other
conditions, and are socially and geographically patterned.
We quantified excess mortality in regions of England
and Wales during the pandemic, for all causes and for
non-COVID-19-associated deaths.
Methods Weekly mortality data for 1 January 2010 to
1 May 2020 for England and Wales were obtained from the
Office of National Statistics. Mean-dispersion negative
binomial regressions were used tomodel death counts based
on pre-pandemic trends and exponentiated linear predictions
were subtracted from: (i) all-cause deaths and (ii) all-cause
deaths minus COVID-19 related deaths for the pandemic
period (week starting 7 March, to week ending 8 May).
Findings Between 7 March and 8 May 2020, there were
47 243 (95% CI: 46 671 to 47 815) excess deaths in
England and Wales, of which 9948 (95% CI: 9376 to
10 520) were not associated with COVID-19. Overall
excess mortality rates varied from 49 per 100 000 (95%
CI: 49 to 50) in the South West to 102 per 100 000 (95%
CI: 102 to 103) in London. Non-COVID-19 associated
excess mortality rates ranged from −1 per 100 000 (95%
CI: −1 to 0) in Wales (ie, mortality rates were no higher
than expected) to 26 per 100 000 (95% CI: 25 to 26) in
the West Midlands.
Interpretation The COVID-19 pandemic has had
markedly different impacts on the regions of England and
Wales, both for deaths directly attributable to COVID-19
infection and for deaths resulting from the national public
health response.
INTRODUCTION
The COVID-19 pandemic began in Hubei Province,
China towards the end of 2019, and the first con-
firmed cases in Britain were recorded on
31 January 2020. As of 21 May 2020, there were
158 488 confirmed cases in England and Wales and
33 081 deaths in people testing positive for SARS-
CoV-2.1 In addition to increased risks for men, older
age groups,2 and people with long-term conditions
such as cardiovascular disease and diabetes, it was
clear from the earliest stages of the pandemic that
the consequences of the outbreak would be more
severe for some social groups, generally those already
most affected by health inequalities. In mid-April,
deaths involving COVID-19 in England ranged
from 25 per 100 000 in the most affluent 10% of
areas to 55 per 100 000 in the most deprived 10%,
following the same social gradient as pre-pandemic
all cause death rates.3 Similar patterns emerged in
Wales. Ethnic minority groups were also
disproportionately affected, with mortality rates in
for Bangladeshi and Pakistani ethnicity over three
times higher than for White, and rates for Black
ethnicity over four times higher.4 To some extent,
these variations may reflect baseline health inequal-
ities across society, but social deprivation also appears
to increase susceptibility to COVID infection specifi-
cally, through factors including overcrowding, work-
ing in a key service or agricultural industry, or having
serious underlying medical conditions that increase
the risk of COVID-related mortality.
The COVID-19 pandemic has also generated geo-
graphic patterns of impact that interact in complex
ways with social patterns. London, a major interna-
tional gateway, was the first area to be substantially
affected and as of mid-May was the region with the
highest number of confirmed cases. However, in
terms of the confirmed infection rate, London was
quickly overtaken by other regions; by 13 May,
COVID-19 rates ranged from 128 per 100 000 in
the South West to 348 per 100 000 in the North
East,1 and hospital admission rates remained highest
in the northern regions,5 where baseline health tends
to be poorer.6 In addition to the impact of the virus
itself, a second epidemic emerged as a result of the
public health response. Many of the excess deaths
during the pandemic are not associated with
COVID-19 infection,7 and although this may be
partly attributable to underdiagnosis, it raises the
possibility that creating emergency capacity in pri-
mary and secondary care has compromised essential
care. Patients have also avoided healthcare providers
out of concern for service pressures or fear of infec-
tion, leading to delay of treatment and increases in
out-of-hospital events such as cardiac arrest.8 9
If these non-COVID-19 excess deaths are also
socially and geographically patterned, the conse-
quences for health inequalities could be severe. To
begin to address this issue, in this study we aimed to
quantify excess mortality in England andWales dur-
ing the pandemic, as an aggregate and by region
(former Strategic Health Authority) and age group,
for all causes and for non-COVID-19-associated
deaths. Socio-economic variability at that high geo-
graphical level is not very meaningful, and we plan
to explore that aspect in future work. We also plan
to update the results weekly, in three online appen-
dices, throughout 2020 and 2021.
METHODS
Data
Weekly mortality data for the whole of England and
Wales were obtained from the Office of National
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Statistics (ONS), covering the period from 1 January 2010 to
8 May 2020.10 All-cause deaths and deaths where the under-
lying cause was respiratory disease were available for England-
Wales as an aggregate, but also by region (former Strategic
Health Authority) and age group (under 1, 1–14, 15–44,
45–66, 65–74, 75–84 and 85 or over) for males and females.
Respiratory disease deaths excluded deaths at age under
28 days and were obtained using ICD-10 codes J00-J99. For
2020 data, deaths where COVID-19 was mentioned in the
death certificate were also reported (ICD-10 U07.1 and
U07.2), as England-Wales aggregates but also by region and
age group. However, respiratory and COVID-19 deaths could
be double-counted. Regional counts do not include residents
outside England-Wales or those records where the place of
residence is missing, while age group counts do not include
deaths where age was missing.
Underlying cause of death, as reported in England andWales, is
compatible with WHO recommendations using ICD rules (with
small changes in 2011 and 2014), and is obtained from the death
certificate. The underlying cause of death is defined by theWHO
as the disease or injury that initiated the series of events that led
directly to death, or the circumstances of the accident or violence
that produced the fatal injury.11 A condition mentioned in the
death certificate may be the main reason or a contributory reason
to the cause of death.
The study used aggregated national mortality data reported by
the ONS, and ethical approval was not needed.
Analyses
Data were imported, cleaned and formatted as a time series in
Stata v16. Death counts, overall and by stratum of interest were
plotted and the same analysis model was used for each. For the
excess mortality modelling, data from week 9 in 2020 (22–
28 February), 2 weeks before the first official COVID-19 related
deaths (7–13March) were set to missing. Mean-dispersion nega-
tive binomial regressions were used to model death counts, with
the fixed-effect predictors being week (as categorical, to account
for seasonality) and time (as continuous, to account for
a potential slope). For each model and stratum, the natural
logarithm of the annual population estimate was used as offset
(which was varying over time). We selected negative binomial
regression models over Poisson models because of the high varia-
tion in the outcome variable. For weeks 11 (7–13 March) to 19
(2–8May), the exponentiated linear prediction from each model
(and its 95% CIs) were subtracted from: (1) all-cause deaths and
(2) all-cause deaths minus deaths where COVID-19 was men-
tioned. Excess death estimates, in each stratum and overall, were
summed across all weeks, with a pooled estimate for the SE used
to obtain the 95% CIs.
RESULTS
All-cause excess mortality
During the 9-week period from 7 March 2020 to 8 May 2020,
overall excess deaths for England and Wales were 47 243 (95%
CI: 46 671 to 47 815) (table 1). This total includes negative
values at the start of the study period, when excess deaths were
lower than predicted from historical trends, continuing a pattern
of relatively low mortality rates in the first 12 weeks of 2020
(figure 1). London had the greatest number of excess deaths at
9219 (95% CI: 9185 to 9254), followed by the North West with
6951 (95% CI: 6903 to 6999) and the South East with 6656
(95% CI: 6588 to 6723). The least affected regions were Wales
with 1757 (95%CI: 1730 to 1784) and theNorth East with 2239
deaths (95% CI: 2209 to 2270). The age-groups with the largest
numbers of excess deaths were 85 or over with 20 173 (95% CI:
19 975 to 20 370) and 75–84 with 14 414 (95% CI: 14 304 to
14 524). We estimated 7021 (95% CI: 6963 to 7078) excess all-
cause deaths for people aged 65–74 and 4811 (95% CI: 4768 to
4853) for people aged 45–64.
All-cause excess mortality per 100 000 population is presented
in table 2, with the average across England andWales at 79 (95%
CI: 78 to 80). The largest mortality rates were observed in
London (102; 95% CI: 102 to 103), the West Midlands (97;
95% CI: 96 to 98) and the North West (94; 95% CI: 93 to 95)
and the lowest in the South West (49; 95% CI: 49 to 50) and
Wales (55; 95% CI: 55 to 56) (figure 2). The mortality rates for
people aged 85 or over, 75–84, 65–74 and 45–64 were 1331
(95% CI: 1318 to 1344), 388 (95% CI: 385 to 391), 118 (95%
CI: 117 to 117) and 31 (95% CI: 31 to 32), respectively.
Excess all-cause deaths were estimated for all male and female
age groups, and were higher for males for all age groups from age
15, with the exception of the 85+ age group. We estimated 9086
(95%CI: 9013 to 9159) excess all-cause deaths for males aged 85
or over, compared to 11 123 for females (95% CI: 10 997 to
11 250). However, males aged 75–84 were estimated to have had
8540 deaths (95% CI: 8481 to 8598), compared to 5890 (95%
CI: 5836 to 5944) for females, and males aged 65–74 were
estimated to have had 4662 deaths (95% CI: 4628 to 4696),
compared to 2360 (95% CI: 2334 to 2386) for females.
Mortality rates per 100 000 population more clearly demon-
strated the higher excess deaths in males. For males aged 85 or
over, 75–84, 65–74 and 45–64, these were estimated at 1602
(95% CI: 1589 to 1615), 503 (95% CI: 500 to 507), 162 (95%
CI: 161 to 164) and 42 (95% CI: 41 to 42). Female estimates for
the respective age groups were 1,173 (95% CI: 1160 to 1186),
291 (95% CI: 289 to 294), 76 (95% CI: 75 to 77) and 21 (95%
CI: 21 to 22).
All-cause excess mortality not attributed to COVID-19
From 7 March 2020 to 8 May 2020, overall excess deaths for
England and Wales, excluding cases where COVID-19 was men-
tioned in the death certificate, were 9948 (95% CI: 9376 to
10 520) (table 3). It is important to note that until the week
ending 1 May 2020, the total was 11 141 (95% CI: 10 567 to
11 714), but there was a large drop into negative values in the last
week of analysis (2 May to 8 May 2020). London was again the
worst-hit region in terms of number of excess deaths with 1814
(95% CI: 1780 to 1849), followed by the South East with 1570
(95% CI: 1502 to 1637) and theWest Midlands with 1531 (95%
CI: 1483 to 1579) (figure 3). The least affected regions were
again Wales with −18 (95% CI: −45 to 9) and the North East
with 320 (95% CI: 290 to 351). The age-groups with the largest
numbers of excess deaths were 85 or over with 5124 (95% CI:
4926 to 5321) and 75–84 with 2207 (95% CI: 2097 to 2317).
Estimated excess deaths for people aged 65–74 and 45–64 were
1249 (95% CI: 1191 to 1306) and 969 (95% CI: 926 to 1011),
respectively.
Non-COVID-19 excess mortality per 100 000 population is
presented in table 4, with the average across England andWales at
17 (95% CI: 16 to 18). The largest mortality rates were in the
West Midlands (26; 95% CI: 25 to 26), followed by the East of
England (21; 95%CI: 20 to 21), the NorthWest (20; 95%CI: 19
to 21) and London (20; 95% CI: 20 to 21) (figure 4). Rates for
people aged 85 or over, 75–84, 65–74 and 45–64 were 338 (95%
CI: 325 to 351), 59 (95% CI: 56 to 62), 21 (95% CI: 20 to 22)
and 6 (95% CI: 6 to 7), respectively.
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Table 1 Excess all-cause deaths from negative binomial regression model, 22/2/2020 to 8/5/2020
Week ending
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Excess all-cause deaths, excluding deaths where COVID-19
was documented cause of death on the death certificate, were
higher for males for all age groups from age 45, with the excep-
tion of the 85+ age group. We estimated 3250 (95% CI: 3124 to
3377) excess deaths for females aged 85 or over, compared to
1910 for males (95% CI: 1837 to 1983). However, males were
estimated to have had 1214 (95% CI: 1155 to 1272), 863 (95%
CI: 829 to 897) and 614 (95% CI: 587 to 640) excess deaths for
age groups 75–84, 65–74 and 45–64, respectively. By compar-
ison, females were estimated to have had 1009 (95% CI: 955 to
1063), 387 (95% CI: 361 to 413) and 352 (95% CI: 334 to 370)
excess deaths for age groups 75–84, 65–75 and 45–64, respec-
tively. Males also had higher non-COVID-19 mortality rates per
100 000 population, with 337 (95% CI: 324 to 350) for males
aged 85 or over, 72 (95%CI: 68 to 75) for males aged 75–84, and
30 (95%CI: 29 to 31) formales aged 65–74. Female estimates for
the respective age groups were 343 (95% CI: 329 to 356), 50
(95% CI: 47 to 53) and 12 (95% CI: 12 to 13).
Supplemental files
Three dynamic supplemental files are also provided, produced in
LaTeX for almost complete automation, which will be updated
weekly. Online appendix 1 reports the graphs presented in the
paper, time-series of excess deaths by region, but also time series
of excess deaths by age group and sex. Online appendix 2 reports
absolute numbers, online appendix 3 reports rates over 100 000
population, for each stratum of interest. For the overall England-
Wales aggregate, each region and each age group (sex specific or
not), we report the following time-series: mortality, mortality
and predictions from the negative binomial regressionmodel, all-
cause excess deaths and all-cause excess deaths where COVID-19
is not mentioned in the death certificate. All these time series are
reported from the 1st week of 2010, the 1st week of 2019 and the
1st week of 2020 (to allow for a more complete overview).
DISCUSSION
Our models, based on historical mortality trends, illustrate the
scale of the COVID-19 pandemic and its direct and indirect
impacts on population health. Over the first 9 weeks, there
were 47 243 excess deaths (95% CI: 46 617 to 47 815) in
England and Wales, of which over a fifth (9948, 95% CI: 9376
to 10 520) were not directly attributed to COVID-19 infection.
This large estimate of excess deaths not linked to COVID-19 is in
agreement with what has been reported elsewhere. This likely
underestimates the impact of the virus, as prior to the pandemic
mortality rates for 2020 were relatively low, particularly com-
pared with years with high influenza activity (2014/15 and 2017/
18). Excess death rates started to increase after 20 March and
peaked between 17 and 24 April, with the highest peaks (up to 26
deaths per 100 000) in London, theWestMidlands and theNorth
West and the lowest peaks in the East Midlands, Wales and the
South West. Non-COVID-19-associated deaths followed similar
general patterns. As has been previously reported, we observed
that males had larger excess mortality rates than females across all
age groups. However, female excess mortality rates excluding
COVID-19 were higher in the 85+ age group, indicating
a large undocumented impact of the virus on older females,
which is likely to be both direct and indirect.
Strengths and limitations
This analysis of national data for England and Wales provides
a comprehensive picture of excess deaths due to COVID-19,
either directly or indirectly, based on diagnosis by clinicians
closely involved with patient care. This allows for the clinical
judgement of the contribution of pandemic coronavirus to death,
and does not only rely on a positive test for COVID-19 infection.
However, there are several important limitations. Although
counts of deaths are likely to be accurate, cause of death
information is less reliable, as it is reliant on accurate diagnosis
and recording by clinicians dealing with exceptional circum-
stances. ONS reports of COVID-19-related deaths are based
Table 1 Continued
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*Week first COVID-19 related deaths were officially reported.
































Figure 1 All-cause excess mortality by region, ranked by highest to
lowest total.
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Table 2 Excess all-cause deaths per 100 000 population from negative binomial regression model, 22/2/2020 to 8/5/2020
Week ending
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on clinical judgements, which in some cases will have been
made without positive PCR or antibody testing. Although this
confers some advantages compared to solely relying on the
presence of a positive test, particularly when the sensitivity
of these tests varies between 66.0% and 97.8%,12 unexpected
deaths in elderly multimorbid patients or in those with respira-
tory symptoms may be misattributed to COVID-19. We con-
trolled for annual population size, while our analyses are
weekly, since changes in the population structure are small
and gradual and not available on a weekly basis. In addition,
the analyses were not age-standardised, and differences in
populations across regions may explain some of the observed
regional variability. Data for the latest weeks are provisional,
subject to updates in later ONS releases, and the ONS reports
the date of registration, rather than date of death, resulting in
fluctuations in counts during certain periods (eg, over Easter).
Finally, in assessing the unintended consequences of the public
health response, it is important to note that we estimated net
excess deaths. We do not know how many deaths have been
avoided by adopting public health social isolation measures,
either through reducing exposure to COVID-19 itself or
through spill-over benefits such as reduced road traffic fatal-
ities. Prediction models estimated that mortality rates due to
COVID-19 infection, in the absence of mitigation, would
reach 3000 deaths per day in England & Wales by the end
of May 2020, and over 460 000 deaths in total by August,13
a much higher burden of death than observed in this study for
both COVID-19 and non-COVID-19 related mortality.
Findings
Over a fifth of excess deaths during the study period did not have
a diagnosis of COVID-19 infection recorded on the death certi-
ficate. This may be partly attributable to missed diagnoses, for
example, where testing did not occur, there was a false negative
result or infection did not produce noticeable symptoms. The risk
of missed diagnosis is likely to have reduced over time, as capacity
for testing has increased, the tests have become more accurate
and clinicians were encouraged to record suspected COVID-19
infection on death certificates.14 This may even have resulted in
bias in the opposite direction, with deaths misattributed to
COVID-19 infection later in the outbreak, which may partly
explain the negative values for non-COVID-19 excess deaths in
the week ending 8 May. Nevertheless, our results suggest that
focusing the health service and wider society on managing
a single disease has had unintended consequences. Creating capa-
city within the health system tomanage anticipated demand from
patients infected with COVID-19 necessitated the cessation of
‘non-essential’ activity—in reality, non-urgent activity. In addi-
tion to reduced supply, there was a simultaneous reduction in
demand from patients seeking to protect health services and
avoid exposure. As a result, attendances in A&E departments in
England in April 2020 were 57% lower than in 2019 and emer-
gency hospital admissions were 39% lower,15 while access to
health services for people with pre-existing conditions was 20%
lower during the COVID-19 peak period.16 Non-attendancemay
have serious immediate consequences, with a reduction in high
acuity attendances requiring urgent admission such as acute cor-
onary syndromes, strokes and heart failure. The focus on protect-
ing the NHS also exposed those dependent on the social care
sector,17 particularly high-risk residents living in close proximity
in care homes. Both COVID-19 and non-COVID-19 deaths rose
rapidly in these settings,18 accounting for over half of all excess
deaths in England and Wales.
The observed differences in impacts of COVID-19 across the
regions of England and Wales have a range of potential causes that
will need to be explored in further detail. COVID-19 spreads
through close human contact, and high rates of infection quickly
developed in the major conurbations, particularly London,
Birmingham (West Midlands), Liverpool and Manchester (North
West), and this is reflected in regional excess mortality rates.
Following exposure, there are several key risk factors for adverse
outcomes, including age, ethnicity, multi-morbidity (particularly
diabetes, cardiovascular disease, and conditions and treatments
suppressing the immune system), smoking and obesity. However,
with respect to age, the regions with the lowest—rather than the
highest—proportion of the population over the age of 65 (London,
Table 2 Continued
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*Week first COVID-19 related deaths were officially reported.








































Figure 2 All-cause excess mortality per 100 000 population by region,
ranked by highest to lowest total.
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Table 3 Excess all-cause deaths, minus those with documented COVID-19 infection, from negative binomial regression model, 22/2/2020 to 8/5/2020
Week ending
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*Week first COVID-19 related deaths were officially reported.
†Sums across age groups and regions do not necessarily correspond to the England-Wales aggregate due to missing postcodes or ages for some deaths and different models used across
population strata.
Table 4 Excess all-cause deaths, minus those with documented COVID-19 infection, per 100 000 population, from negative binomial regression
model, 22/2/2020 to 8/5/2020
Week ending
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the West Midlands and the North West) had the highest rates of
excess deaths, although older populations within the regions were
most affected. London is an outlier in terms of age, with only 12.1%
of the population over age 65 and 1.7% over age 85 compared to
18.5% and 2.5%, respectively, for England and Wales, but it was
disproportionately affected by the pandemic in its early stages.With
respect to ethnicity, Wales and the North East have the smallest
BAME populations and London by far the highest.19 Other key risk
factors, including obesity, smoking and multimorbidity are strongly
associated with deprivation,20 21 the highest concentrations of
which are found in the North East, North West,22 and the south
of Wales.23 Regional rates of excess deaths were not clearly asso-
ciated with levels of deprivation, although within regions more
deprived communities have been disproportionately affected,2
reflecting higher prevalence of risk factors, ability to comply with
social distancing requirements and exposure to air pollution.24 The
low estimates of excess deaths in Wales may be partially due to the
somewhat different and arguablymore conservative handling of the
pandemic by the devolved Welsh Government.
To date, trends in non-COVID-19 related excess deaths
during the pandemic have followed the same general pattern
as all-cause excess deaths, with some English regions and
Wales appearing to be relatively unaffected. This may reflect
factors such as differences in: levels of testing, thresholds
for diagnosis, sociodemographic structures, levels of rurality,
Table 4 Continued
Week ending

















































































































































































































































*Week first COVID-19 related deaths were officially reported.
















































Figure 4 All-cause minus COVID-19 related excess mortality per






































Figure 3 All-cause minus COVID-19 related excess mortality by region,
ranked by highest to lowest total.
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service engagement by older patients, and capacities within
local health and social care systems. As the pandemic devel-
ops, the balance between COVID-19 and non-COVID-19-
related deaths is likely to change, and different patterns may
develop across the regions. These patterns will need to be
monitored as the longer-term impacts of the pandemic and
the public health response emerge.
CONCLUSION
Short-term trends in excess deaths during the COVID-19
pandemic have not followed typical regional patterns for
premature mortality in England and Wales, particularly for
deaths not directly attributable to the virus. Some regions
where mortality rates tend to be low, for example, the
South East and East, have had relatively high rates of non-
COVID-19-related deaths. Predicting longer-term impacts
requires caution, but given the sudden and comprehensive re-
prioritisation of services, it is likely that a second wave of
non-COVID-19-related need is currently building in the com-
munity. When this breaks it could overwhelm parts of the
NHS, and communities with high baseline levels or morbidity
are likely to be hit harder than others and this should be
recognised in planning post-pandemic health and social care
services.25 The national response will need to address local
variations in viral activity, in health and social care provision,
and in pandemic preparedness, including management of
‘routine’ care during a national emergency. It will also need
to address long-standing structural disadvantages that expose
parts of the country to avoidable harm from both chronic
and acute infectious disease.
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